Eli Lilly Rolls Out Weight-loss Pill Foundayo in UK

MT Newswires · 2d ago
10:39 AM EDT, 08/24/2026 (MT Newswires) -- Eli Lilly (LLY.SW, LLY.F) launched its Foundayo, or orforglipron, pill for weight management and type 2 diabetes in the UK, Reuters reported Monday, citing a statement from the company. Patients will have access to the GLP-1 receptor agonist through private prescription in the UK, which is the first country in Europe where the pill is available, the report noted. The pharmaceutical giant obtained marketing authorization from the UK's Medicines and Healthcare products Regulatory Agency earlier in August.